Bristol-Myers Misses Estimates as Cancer, Virus Drug Sales Slow

Bristol-Myers Misses Estimates as Cancer, Virus Drug Sales Slow


Bristol-Myers Squibb Co. reported fourth-quarter profit that fell short of analysts' estimates as sales slowed for its virology drugs and cancer treatment Yervoy.



from Biotech News